Doctoral Degree
Ph.D., Experimental Pathology, University of Virginia (2018)
Master's Degrees
- M.P.H., Harvard University (2021)
- M.S., University of Virginia (2016)
- M.S., University of California San Diego (2014)
Research Interests
Breast Cancer Etiology; Risk Factors; Tumor Microenvironment; Cancer Disparities
Primary Preceptor/Branch/Division
Gretchen Gierach, Ph.D., M.P.H., Integrative Tumor Epidemiology Branch (ITEB), Division of Cancer Epidemiology and Genetics (DCEG)
Secondary Preceptor/Branch/Division
Stefan Ambs, Ph.D., M.P.H., Laboratory of Human Carcinogenesis (LHC), Center for Cancer Research (CCR)
Publications
Lord BD, Harris AR, Ambs S. The impact of social and environmental factors on cancer biology in Black Americans. Cancer Causes Control. 2023 Mar;34(3):191-203. doi: 10.1007/s10552-022-01664-w. Epub 2022 Dec 23. PMID: 36562901.
Wallace IJ, Kraft TS, Venkataraman VV, Davis HE, Holowka NB, Harris AR, Lieberman DE, Gurven M. Cultural variation in running techniques among non-industrial societies. Evol Hum Sci. 2022;4:e14. doi: 10.1017/ehs.2022.12. Epub 2022 Apr 11. PMID: 36325185.
Harris AR, Esparza S, Azimi MS, Cornelison R, Azar FN, Llaneza DC, Belanger M, Mathew A, Tkachenko S, Perez MJ, Rosean CB, Bostic RR, Cornelison RC, Tate KM, Peirce-Cottler SM, Paquette C, Mills A, Landen CN, Saucerman J, Dillon PM, Pompano RR, Rutkowski MA, Munson JM. Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy. Front Oncol. 2022 Mar 17;12:801764. doi: 10.3389/fonc.2022.801764. eCollection 2022. PMID: 35372032.
Beeghly GF, Thomas C, Yuan JX, Harris AR, Munson JM. Designing Patient-Driven, Tissue-Engineered Models of Primary and Metastatic Breast Cancer. Bioengineering (Basel). 2022 Jan 18;9(2):44. doi: 10.3390/bioengineering9020044. PMID: 35200398.
Cornelison R, Biswas K, Llaneza DC, Harris AR, Sosale NG, Lazzara MJ, Landen CN. CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer. Cancers (Basel). 2021 Oct 9;13(20):5056. doi: 10.3390/cancers13205056. PMID: 34680204.
Shim S, Belanger MC, Harris AR, Munson JM, Pompano RR. Two-way communication between ex vivo tissues on a microfluidic chip: application to tumor-lymph node interaction. Lab Chip. 2019 Mar 13;19(6):1013-1026. doi: 10.1039/c8lc00957k. PMID: 30742147.
Harris AR, Perez MJ, Munson JM. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. BMC Cancer. 2018 Jul 6;18(1):718. doi: 10.1186/s12885-018-4619-8. PMID: 29976154.
Harris AR, Yuan JX, Munson JM. Assessing multiparametric drug response in tissue engineered tumor microenvironment models. Methods. 2018 Feb 1;134-135:20-31. doi: 10.1016/j.ymeth.2017.12.010. Epub 2017 Dec 16. PMID: 29258924.
Ledur PF, Liu C, He H, Harris AR, Minussi DC, Zhou HY, Shaffrey ME, Asthagiri A, Lopes MB, Schiff D, Lu YC, Mandell JW, Lenz G, Zong H. Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. Neuro Oncol. 2016 Oct;18(10):1413-24. doi: 10.1093/neuonc/now062. Epub 2016 Apr 21. PMID: 27106408.
de Jong PR, Taniguchi K, Harris AR, Bertin S, Takahashi N, Duong J, Campos AD, Powis G, Corr M, Karin M, Raz E. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016 May 17;7:11551. doi: 10.1038/ncomms11551. PMID: 27187615.
de Jong PR, Takahashi N, Harris AR, Lee J, Bertin S, Jeffries J, Jung M, Duong J, Triano AI, Lee J, Niv Y, Herdman DS, Taniguchi K, Kim CW, Dong H, Eckmann L, Stanford SM, Bottini N, Corr M, Raz E. Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis. J Clin Invest. 2014 Sep;124(9):3793-806. doi: 10.1172/JCI72340. Epub 2014 Aug 1. PMID: 25083990.
de Jong PR, Mo JH, Harris AR, Lee J, Raz E. STAT3: An Anti-Invasive Factor in Colorectal Cancer? Cancers (Basel). 2014 Jul 3;6(3):1394-407. doi: 10.3390/cancers6031394. PMID: 24995503.